Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ)
CNY 12.29
(-0.32%)
CNY 12.29
(-0.32%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 724.6 Million CNY | -19.68% |
| 2022 | 902.17 Million CNY | 74.51% |
| 2021 | 516.98 Million CNY | -27.8% |
| 2020 | 716 Million CNY | -19.93% |
| 2019 | 894.25 Million CNY | 6.93% |
| 2018 | 836.27 Million CNY | 90.95% |
| 2017 | 437.95 Million CNY | 502.93% |
| 2016 | 72.63 Million CNY | -57.96% |
| 2015 | 172.77 Million CNY | 205.8% |
| 2014 | 56.5 Million CNY | 73.85% |
| 2013 | 32.5 Million CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | -100.0% |
| 2009 | 40 Million CNY | -53.77% |
| 2008 | 86.51 Million CNY | -3.87% |
| 2007 | 90 Million CNY | 38.46% |
| 2006 | 65 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 675.79 Million CNY | -88.16% |
| 2024 Q2 | 2.58 Million CNY | -99.4% |
| 2024 Q1 | 430.08 Million CNY | -40.65% |
| 2023 Q4 | 724.6 Million CNY | 3.39% |
| 2023 Q1 | 597.9 Million CNY | -33.73% |
| 2023 FY | 724.6 Million CNY | -19.68% |
| 2023 Q3 | 700.83 Million CNY | 32.92% |
| 2023 Q2 | 527.25 Million CNY | -11.82% |
| 2022 Q2 | 828.24 Million CNY | 20.22% |
| 2022 Q1 | 688.92 Million CNY | 33.26% |
| 2022 Q3 | 1.15 Billion CNY | 39.41% |
| 2022 FY | 902.17 Million CNY | 74.51% |
| 2022 Q4 | 902.17 Million CNY | -21.87% |
| 2021 Q4 | 516.98 Million CNY | -29.9% |
| 2021 Q1 | 753.23 Million CNY | 5.2% |
| 2021 FY | 516.98 Million CNY | -27.8% |
| 2021 Q3 | 737.49 Million CNY | -7.57% |
| 2021 Q2 | 797.85 Million CNY | 5.92% |
| 2020 Q2 | 1.04 Billion CNY | -11.72% |
| 2020 Q4 | 716 Million CNY | -29.35% |
| 2020 Q3 | 1.01 Billion CNY | -2.65% |
| 2020 Q1 | 1.17 Billion CNY | 31.87% |
| 2020 FY | 716 Million CNY | -19.93% |
| 2019 Q4 | 894.25 Million CNY | 16.53% |
| 2019 FY | 894.25 Million CNY | 6.93% |
| 2019 Q3 | 767.37 Million CNY | -32.01% |
| 2019 Q2 | 1.12 Billion CNY | -10.41% |
| 2019 Q1 | 1.25 Billion CNY | 50.65% |
| 2018 Q3 | 881.65 Million CNY | 36.56% |
| 2018 Q4 | 836.27 Million CNY | -5.15% |
| 2018 FY | 836.27 Million CNY | 90.95% |
| 2018 Q1 | 676.05 Million CNY | 54.37% |
| 2018 Q2 | 645.6 Million CNY | -4.51% |
| 2017 Q1 | 30 Million CNY | -58.7% |
| 2017 FY | 437.95 Million CNY | 502.93% |
| 2017 Q4 | 437.95 Million CNY | 4.79% |
| 2017 Q3 | 417.95 Million CNY | 221.61% |
| 2017 Q2 | 129.95 Million CNY | 333.2% |
| 2016 Q2 | 180.59 Million CNY | 198.5% |
| 2016 Q1 | 60.49 Million CNY | -64.98% |
| 2016 FY | 72.63 Million CNY | -57.96% |
| 2016 Q4 | 72.63 Million CNY | -44.78% |
| 2016 Q3 | 131.53 Million CNY | -27.16% |
| 2015 Q3 | 87.49 Million CNY | -36.36% |
| 2015 Q2 | 137.49 Million CNY | 139.13% |
| 2015 FY | 172.77 Million CNY | 205.8% |
| 2015 Q1 | 57.49 Million CNY | 1.77% |
| 2015 Q4 | 172.77 Million CNY | 97.46% |
| 2014 Q1 | 32.5 Million CNY | 0.0% |
| 2014 Q4 | 56.5 Million CNY | 0.0% |
| 2014 Q3 | 56.5 Million CNY | 0.0% |
| 2014 FY | 56.5 Million CNY | 73.85% |
| 2014 Q2 | 56.5 Million CNY | 73.85% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2013 FY | 32.5 Million CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 Q4 | 32.5 Million CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2011 Q2 | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2011 Q3 | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2011 Q1 | - CNY | 0.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2010 Q3 | - CNY | 0.0% |
| 2010 Q1 | - CNY | -100.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2010 FY | - CNY | -100.0% |
| 2009 Q2 | 80.05 Million CNY | 0.0% |
| 2009 Q3 | 50 Million CNY | -37.55% |
| 2009 Q4 | 40 Million CNY | -20.0% |
| 2009 FY | 40 Million CNY | -53.77% |
| 2008 FY | 86.51 Million CNY | -3.87% |
| 2008 Q4 | 86.51 Million CNY | 0.0% |
| 2007 FY | 90 Million CNY | 38.46% |
| 2006 FY | 65 Million CNY | 0.0% |